The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Vanguard Emerging Markets Stock Index Fund

NYSE: VWO
Last

(U.S.) $41.42

Today's change+0.55 +1.35%
Updated April 1 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Vanguard Emerging Markets Stock Index Fund

NYSE: VWO
Last

(U.S.) $41.42

Today's change+0.55 +1.35%
Updated April 1 4:00 PM -4GMT. Delayed by at least 15 minutes.

Vanguard Emerging Markets Stock Index Fund Hits New 20-day High

Vanguard Emerging Markets Stock Index Fund closed up Wednesday by (U.S.)$0.55 or 1.35% to (U.S.)$41.42 and setting a new 20-day high. Over the last five days, shares have gained 2.98% and 3.50% year to date. Shares have underperformed the S&P 500 by 8.14% during the last year.

Key company metrics

  • Open(U.S.) $41.29
  • Previous close(U.S.) $40.87
  • High(U.S.) $41.52
  • Low(U.S.) $41.20
  • Bid / Ask-- / --
  • YTD % change+3.50%
  • Volume19,184,925
  • Average volume (10-day)11,956,564
  • Average volume (1-month)12,104,346
  • Average volume (3-month)12,438,188
  • 52-week range(U.S.) $37.30 to (U.S.) $46.49
  • Beta1.20
  • Trailing P/E30.59×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.11
  • Dividend yield2.68%
  • Trailing EPS(U.S.) $1.35
Updated April 1 4:00 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q2/2014Q4/2013Q2/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 31, 201410/31/2014Apr 30, 201404/30/2014Oct 31, 201310/31/2013Apr 30, 201304/30/2013
Revenue923396895517
Total other revenue--------
Total revenue923396895517
Gross profit--------
Total cost of revenue--------
Total operating expense21182127
Selling / general / administrative21182127
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income902378874490
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax2,990-1,229-1,5073,910
Income after tax2,990-1,229-1,5073,910
Income tax, total0000
Net income2,990-1,229-1,5073,910
Total adjustments to net income--------
Net income before extra. items2,990-1,229-1,5073,910
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,990-1,229-1,5073,910
Inc. avail. to common incl. extra. items2,990-1,229-1,5073,910
Diluted net income2,990-1,229-1,5073,910
Dilution adjustment--00--
Diluted weighted average shares1,1901,0601,0871,329
Diluted EPS excluding extraordinary itemsvalue per share2.51-1.16-1.392.94
Dividends per sharevalue per share0.860.320.850.51
Diluted normalized EPSvalue per share2.51-1.16-1.392.94